Brent Pfeiffenberger
Board Member
Corbus Pharmaceuticals Holdings, Inc. (CRBP)Chairman
Century Therapeutics, Inc. (IPSC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brent Pfeiffenberger
Brent Pfeiffenberger is recorded as CEO and Chairman at Century Therapeutics, Inc. (IPSC) and Board Member at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 14, 2026 that Brent Pfeiffenberger was appointed member of the Board, effective May 13, 2026. Century Therapeutics, Inc. reported in an 8-K filed November 14, 2023 that Brent Pfeiffenberger was appointed member of the Board, effective December 4, 2023. Century Therapeutics, Inc. reported in an 8-K filed November 14, 2023 that Brent Pfeiffenberger was appointed President and Chief Executive Officer, effective December 4, 2023.
“On May 13, 2026, the board of directors (the "Board") of Corbus Pharmaceuticals Holdings, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Brent Pfeiffenberger, age 48, to serve as a member of the Board, thereby expanding the Board to seven members.”
“Concurrently with his appointment as President and Chief Executive Officer and effective as of the Effective Date, Dr. Pfeiffenberger was appointed to serve as a member of the Board and the size of the Board will increase to eight directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-13–present
-
Current
2025-08-14–present
-
Current
Start not stated–present
-
2024-01-01–2024-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Century Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gregory Russotti, Ph.D. CEO
- Brent Pfeiffenberger, Pharm.D. Chairman
- Douglas Carr CFO
- Michael Diem CFO
- Morgan Conn, Ph.D. CFO
- Gregory Russotti CTO
- Alessandro Riva Board Member
- Dr. Han Lee Board Member
- Dr. Martin Murphy Board Member
- Han Lee Board Member
Leadership on record at Corbus Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Ian Hodgson COO, Board Member
- Alan Holmer Board Member
- Anne Altmeyer Board Member
- Anne Altmeyer, Ph.D., MBA, MPH Board Member
- Avery W. Catlin Board Member
- Dominic Smethurst Board Member
- George S. Golumbeski Board Member
- John Jenkins Board Member
- Rachelle Jacques Board Member
- Sean Moran Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.